# Mechanistically-Specific Hypotheses: EV-Derived Biomarkers for Early/Prodromal AD
---
## Hypothesis 1: Neuron-Derived EV p-tau231 as Ultra-Early Diagnostic Marker
### Mechanism
Neuron-derived extracellular vesicles (NDEVs) isolated via L1CAM (CD171) surface capture contain pathologically relevant tau species. Phosphorylation at threonine 231 (p-tau231) occurs upstream of other phosphorylation events in the tau seeding cascade and may reflect early conformational changes in neuronal tau before fibrillization. NDEV p-tau231 likely represents intracellular tau that is actively released via the exosomal pathway during early neurodegenerative priming, before extracellular plaque formation becomes dominant.
### Key Evidence
- Winston et al. (2019) demonstrated that NDEV p-tau181 discriminates AD from controls with AUC > 0.90 (PMID: 31278165)
- Other studies show p-tau231 elevation in CSF of preclinical cases
### Testable Prediction
If p-tau231 in NDEVs reflects early intraneuronal tau pathology, then longitudinal sampling should show p-tau231 elevation **prior to** detectable increases in plasma p-tau181 or p-tau217 in cognitively normal individuals who later convert to MCI/AD. This would be tested by comparing baseline NDEV p-tau231 levels between converters vs. non-converters over 3-5 years using ultrasensitive Simoa assay. Falsification: if NDEV p-tau231 does not precede plasma p-tau181 changes, the hypothesis is rejected.
### Primary Target
**MAPT** (tau protein), specifically p-tau231 epitope
---
## Hypothesis 2: Synaptic Vesicle Protein SV2C as Marker of Presynaptic Terminal Vulnerability
### Mechanism
Synaptic vesicle protein 2C (SV2C) is selectively enriched in a subset of cortical synapses (particularly cholinergic terminals) and is trafficked into neuronal EVs via AP-2/clathrin-mediated endocytosis followed by intraluminal vesicle formation. Unlike broadly expressed synaptic proteins (SNAP-25, synapsin-1), SV2C's restricted expression pattern may make its EV levels more specific for vulnerable synaptic populations. Reductions in NDEV SV2C may therefore reflect early terminal loss before volumetric changes.
### Key Evidence
- Decreased SV2C expression is observed in AD prefrontal cortex (PMID: 27260880)
- EV synaptic protein cargo reflects synaptic activity and turnover rates
### Testable Prediction
If SV2C in NDEVs specifically reflects cholinergic terminal integrity, then NDEV SV2C levels should correlate with **CSF cholinergic markers** (e.g., acetylcholinesterase activity) and show greater deficit than NDEV SNAP-25 in prodromal AD. Falsification: if SV2C levels in NDEVs do not correlate with cholinergic markers or show equivalent decline to other synaptic proteins, the specificity claim is rejected.
### Primary Target
**SV2C** (Synaptic Vesicle Protein 2C)
---
## Hypothesis 3: Microglial EV Cargo TREM2 and Complement C1q as Neuroinflammatory Signatures
### Mechanism
Microglia-derived EVs (MDEVs) isolated by CD11b (ITGAM) capture carry complement cascade components and TREM2 that reflect microglial activation state. Complement C1q initiates the classical pathway and opsonizes synapses for phagocytosis—a mechanism implicated in synaptic loss. MDEV C1q elevation in prodromal AD would indicate complement-mediated "synaptic pruning" is actively occurring. TREM2 variants modulate this response; risk variants (R47H) may alter the cargo profile toward a more phagocytic phenotype.
### Key Evidence
- TREM2 expression on microglia is elevated in AD and modulates disease progression (PMID: 28120856)
- Complement activation precedes synapse loss in AD models (PMID: 25427974)
### Testable Prediction
If MDEV C1q reflects complement-mediated synaptic elimination, then individuals with elevated MDEV C1q will show faster cognitive decline AND greater reduction in NDEV synaptic proteins (from Hypothesis 2), even after controlling for amyloid burden. Falsification: if MDEV C1q levels do not predict synaptic protein decline or cognitive trajectory, the mechanistic link is unsupported.
### Primary Target
**C1QA/C1QB/C1QC** (Complement C1q subcomponents) and **TREM2**
---
## Hypothesis 4: EV-